Brain Tumour Program

The Brain Tumour Program continues to grow into one of the largest childhood brain tumour clinical and research programs in Australia. It sees more than 30 children with newly diagnosed brain tumours every year, who are each managed by a large multi-disciplinary team of experts.

The program is continually expanding the range of clinical trials open to children with brain tumours. This allows patients access to state-of-the-art treatments.  Collaborations with international groups helps to improve treatments for children with aggressive brain tumours such as high grade gliomas, medulloblastoma, and ependymoma.

There is also an active laboratory research program which focuses on the investigation of new treatment strategies for childhood brain tumours. Recently the program initiated the first ever research program in Australia into Diffuse Intrinsic Pontine Gliomas. In this innovative new study, researchers are growing the first Diffuse Intrinsic Pontine Glioma cells ever cultured in a test tube.

This will allow the team to use a new state-of-the-art robotic system to automatically test thousands of drugs against these cells to rapidly find new treatment options for this devastating form of brain cancer. The plan is to harvest further tumour cells donated from patients around Australia to allow further research to develop new treatment strategies for these patients.

For more details contact Associate Professor Richard Cohn (02) 9382 1730 or richard.cohn@sesiahs.health.nsw.gov.au  or Dr David Ziegler (02) 9382 1730 or d.ziegler@unsw.edu.au